Bridge Biotherapeutics, Inc.
Joengbin Ahn is a communications professional with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as the Director Of Communications at Bridge Biotherapeutics, Inc. since August 2018, Joengbin has successfully executed communication strategies aligned with corporate objectives, managed media relations, and led public campaigns to enhance disease awareness and corporate identity. Previously, as a Communication Specialist at Pharmaresearch Products and a Senior Account Executive at Edelman, Joengbin established integrated communication strategies, managed media relations, and coordinated marketing communication projects. Joengbin began the career at Waggener Edstrom Worldwide as an Account Executive and completed an internship with the U.S. Commercial Service. Joengbin holds an MBA in Entrepreneurship from Aalto University and a Bachelor's degree in Communication and Business from Sogang University.
This person is not in any teams
This person is not in any offices
Bridge Biotherapeutics, Inc.
Bridge Biotherapeutics, Inc. is a virtually-operated, venture-backed clinical stage global biotech company, headquartered in Seongnam, Korea with its subsidiary at JLABS@TMC, engaged in the development of novel therapeutics, focusing on therapeutic areas of high unmet medical needs, such as ulcerative colitis, fibrotic diseases, and cancers.